US · MMSI
Merit Medical Systems, Inc.
- Sector
- Healthcare · Medical - Instruments & Supplies
- Headquarters
- South Jordan, UT 84095
- Website
- merit.com
Price · as of 2025-12-31
$62.01
Market cap 4.58B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $80.34 | +29.56% |
| Intrinsic Value(DCF) | $30.60 | -50.65% |
| Graham-Dodd Method(GD) | $29.07 | -53.12% |
| Graham Formula(GF) | $42.17 | -31.99% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | $12.59 | $35.22 | $19.72 | $10.52 | $16.75 |
| 2012 | $12.46 | $28.36 | $6.72 | $7.23 | $8.09 |
| 2013 | $14.64 | $29.41 | $5.36 | $7.14 | $8.29 |
| 2014 | $19.35 | $31.86 | $3.77 | $8.48 | $11.26 |
| 2015 | $18.64 | $31.02 | $0.00 | $9.10 | $7.70 |
| 2016 | $29.85 | $37.66 | $0.00 | $8.71 | $8.62 |
| 2017 | $45.95 | $46.61 | $2.95 | $11.80 | $15.70 |
| 2018 | $57.26 | $53.02 | $43.77 | $15.45 | $22.84 |
| 2019 | $37.58 | $39.49 | $17.52 | $11.33 | $2.00 |
| 2020 | $59.60 | $43.85 | $0.00 | $9.85 | $0.00 |
| 2021 | $62.59 | $64.43 | $0.00 | $16.39 | $16.59 |
| 2022 | $67.07 | $56.49 | $0.00 | $20.37 | $19.45 |
| 2023 | $75.20 | $69.23 | $1.31 | $22.43 | $27.75 |
| 2024 | $99.95 | $78.18 | $0.00 | $26.07 | $32.23 |
| 2025 | $76.50 | $80.34 | $0.00 | $29.07 | $42.17 |
AI valuation
Our deep-learning model estimates Merit Medical Systems, Inc.'s (MMSI) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $80.34
- Current price
- $62.01
- AI upside
- +29.56%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$30.60
-50.65% upside
Graham-Dodd
$29.07
-53.12% upside
Graham Formula
$42.17
-31.99% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| MMSI | Merit Medical Systems, In… | $62.01 | 4.58B | +30% | -51% | -53% | -32% | 35.22 | 2.86 | 2.99 | 14.98 | 715.00 | 8.38 | 48.70% | 12.19% | 8.48% | 8.67% | 7.25% | 5.03% | 0.57 | 6.98 | 4.34 | 2.80 | 1.35 | 493.00% | 1175.00% | 1800.00% | 4.77% | 1.24 | 11.26% | 0.00% | 0.00% | 0.00% | 26.93 | 23.07 | 3.28 | 4.04 |
| ALKS | Alkermes plc | $30.10 | 4.97B | +85% | -49% | -41% | -85% | 20.62 | 2.74 | 3.38 | 13.49 | — | 2.87 | 86.31% | 17.21% | 16.37% | 14.72% | 20.15% | 10.64% | 0.04 | 20.69 | 2.06 | 1.70 | -1.57 | -3410.00% | -525.00% | -9987.00% | 0.01% | 0.00 | 0.05% | 0.00% | 0.00% | 6.08% | 17.58 | 8571.26 | 3.02 | 5.27 |
| BLCO | Bausch + Lomb Corporation | $18.30 | 6.48B | +52% | -60% | — | — | -18.50 | 1.01 | 1.28 | 20.11 | -138.78 | -4.09 | 58.71% | 3.12% | -7.06% | -5.45% | 1.41% | -2.56% | 0.83 | 0.37 | 1.55 | 0.84 | 8.72 | 1333.00% | 647.00% | 1186.00% | -1.01% | 0.15 | -0.59% | 0.00% | 0.00% | 0.00% | 72.33 | -174.25 | 2.25 | 0.92 |
| BRKR | Bruker Corporation | $40.11 | 6.09B | -2% | -60% | -66% | — | 206.96 | 2.44 | 1.76 | 17.43 | — | -7.46 | 45.61% | 6.30% | -0.25% | 1.37% | 2.20% | 0.48% | 0.76 | 4.69 | 1.73 | 0.66 | 3.59 | -11974.00% | 208.00% | -6816.00% | 0.72% | 0.10 | 1.10% | 0.38% | 78.10% | 8.68% | 35.15 | 175.83 | 2.22 | 1.82 |
| GKOS | Glaukos Corporation | $120.40 | 6.99B | -42% | +3% | — | — | -51.83 | 10.56 | 13.65 | -45.16 | -281.48 | 15.48 | 55.72% | -39.33% | -36.99% | -18.78% | -36.24% | -14.31% | 0.21 | -43.06 | 4.69 | 3.82 | -0.32 | 1841.00% | 3233.00% | -2013.00% | -0.78% | -0.46 | -10.09% | 0.00% | 0.00% | 0.00% | -34.01 | -125.68 | 13.38 | 16.38 |
| KRYS | Krystal Biotech, Inc. | $275.64 | 8.06B | -24% | -34% | -72% | +4% | 36.57 | 6.14 | 19.25 | 39.75 | 28.57 | 6.14 | 92.61% | 41.45% | 52.64% | 18.91% | 42.60% | 17.14% | 0.01 | — | 9.95 | 9.28 | -2.90 | 12800.00% | 3394.00% | 5851.00% | 2.52% | 1.95 | 49.90% | 0.00% | 0.00% | 1.99% | 41.37 | 35.32 | 17.15 | 40.89 |
| PTCT | PTC Therapeutics, Inc. | $68.19 | 5.47B | +340% | +35% | -42% | +1,382% | 7.73 | -25.71 | 3.05 | 4.31 | — | -7.80 | 95.85% | 49.49% | 39.44% | -104.75% | -117.79% | 29.58% | -2.40 | 5.63 | 2.35 | 2.20 | -0.55 | -26448.00% | 11451.00% | -48603.00% | 13.31% | 0.73 | -98.57% | 0.00% | 0.00% | 41.37% | 4.47 | 5.45 | 2.21 | 1.69 |
| STVN | Stevanato Group S.p.A. | $15.52 | 4.24B | +118% | -45% | -52% | -68% | 31.27 | 3.57 | 4.54 | 21.56 | — | 3.80 | 27.38% | 14.60% | 10.67% | 12.64% | 7.41% | 7.29% | 0.31 | 23.48 | 1.84 | 1.32 | 1.33 | -2182.00% | 172.00% | -5314.00% | -3.15% | 0.33 | -9.88% | 0.29% | 9.00% | 0.29% | 33.16 | -33.86 | 4.84 | 4.68 |
| TFX | Teleflex Incorporated | $122.06 | 5.39B | -20% | -55% | — | +315% | -6.06 | 1.76 | 2.75 | 17.49 | — | -7.79 | 56.24% | 2.94% | -45.45% | -24.47% | 1.35% | -12.90% | 0.06 | 0.58 | 2.54 | 0.95 | -0.64 | -146824.00% | -3461.00% | -9972.00% | 0.03% | 0.13 | 0.03% | 1.10% | -6.70% | 36.82% | 90.40 | 3659.08 | 2.66 | 2.01 |
| TGTX | TG Therapeutics, Inc. | $30.09 | 4.78B | +200% | +4,085% | -34% | +845% | 9.49 | 6.55 | 6.88 | 33.25 | 0.54 | 6.55 | 83.62% | 20.01% | 72.56% | 102.75% | 36.31% | 54.50% | 0.01 | 4.61 | 4.10 | 2.91 | -0.58 | 174667.00% | 8732.00% | -3840.00% | -0.59% | -0.16 | -7.36% | 0.00% | 0.00% | 5.57% | 33.32 | -164.45 | 6.67 | 6.21 |
| TMDX | TransMedics Group, Inc. | $145.26 | 4.96B | -12% | +2,727% | -71% | +68% | 26.26 | 10.56 | 8.25 | 33.53 | 6.87 | 10.87 | 59.92% | 17.93% | 31.43% | 54.24% | 25.12% | 20.33% | 0.99 | 7.88 | 7.14 | 6.41 | -0.13 | 38218.00% | 3713.00% | -26504.00% | 2.67% | 2.16 | 30.90% | 0.00% | 0.00% | 4.01% | 45.85 | 37.27 | 8.22 | 6.19 |
About Merit Medical Systems, Inc.
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
- CEO
- Martha Goldberg Aronson
- Employees
- 7.4K
- Beta
- 0.61
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($30.60 ÷ $62.01) − 1 = -50.65% (DCF, example).